Publication | Closed Access

Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone

Medicinal ChemistryExperimental Vesicant ActivityAnticancer Agents CisplatinMedicinePharmacologyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer Research